Alliance seeks to boost regional capacity in clinical trials

Deakin University

Thursday, 23 April, 2026

Alliance seeks to boost regional capacity in clinical trials

The Barwon Health–Deakin University Clinical Trials Alliance is intended to grow a regionally embedded but globally responsive partnership. Drawing on the complementary strengths of Barwon Health and Deakin University, by strengthening a longstanding research collaboration, the alliance also aims to place Geelong at the centre of a nationally significant medical research and innovation ecosystem.

“This partnership formally brings together clinical excellence and academic leadership to expand access to high-quality clinical trials close to home,” Barwon Health CEO Frances Diver said. “It means our community can benefit from the latest advances in health care, while ensuring regional voices and experiences help shape the future of medicine.”

Alliance partners have committed $9.6 million in direct investment and in-kind support over five years and will support increased higher degree research and increased access to trials-related training for Barwon Health and Deakin staff — this includes the establishment of the Clinician Scientist PhD Pathway.

“Clinical trials are essential to improve access to innovative treatments and are a key driver of Australia’s health and medical research capacity, supporting national objectives for sovereign capability, skilled jobs and regional development,” said Professor Rachel Huxley, Deakin Distinguished Professor and Executive Dean of the Faculty of Health.

“The initiative complements Australian Government investments in medical research, innovation and advanced manufacturing, showcasing how regional partnerships can contribute to national outcomes.”

Having commenced in January, the alliance was officially launched by Federal Member for Corio Richard Marles at Deakin Waterfront in April.

Image credit: (L–R) Distinguished Professor Matthew Clarke, Deputy Vice-Chancellor Research and Innovation, Deakin University; Richard Marles, Member for Corio; Frances Diver, CEO, Barwon Health; and Distinguished Professor Rachel Huxley, Executive Dean Faculty of Health, Deakin University. Credit: Deakin University

Related News

TGA acts on melatonin imports with infringement notices totalling $99K

Laboratory testing of several imported unregistered melatonin products has confirmed them to be...

Scientists search for cystitis pain 'off switch'

By targeting certain pain receptors in the bladder, Australian scientists believe that the...

Australia's first cases of H5 avian influenza confirmed

Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd